- Home
- RGNX vs BWMX Comparison
RGNX vs BWMX Comparison
Compare RGNX & BWMX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RGNX
- BWMX
- Stock Information
- Founded
- RGNX 2008
- BWMX 1995
- Country
- RGNX United States
- BWMX Mexico
- Employees
- RGNX N/A
- BWMX N/A
- Industry
- RGNX Biotechnology: Biological Products (No Diagnostic Substances)
- BWMX Catalog/Specialty Distribution
- Sector
- RGNX Health Care
- BWMX Consumer Discretionary
- Exchange
- RGNX Nasdaq
- BWMX Nasdaq
- Market Cap
- RGNX 451.1M
- BWMX 495.6M
- IPO Year
- RGNX 2015
- BWMX N/A
- Fundamental
- Price
- RGNX $9.03
- BWMX $13.49
- Analyst Decision
- RGNX Strong Buy
- BWMX Strong Buy
- Analyst Count
- RGNX 8
- BWMX 2
- Target Price
- RGNX $28.50
- BWMX $22.50
- AVG Volume (30 Days)
- RGNX 502.6K
- BWMX 33.4K
- Earning Date
- RGNX 11-05-2025
- BWMX 10-23-2025
- Dividend Yield
- RGNX N/A
- BWMX 10.84%
- EPS Growth
- RGNX N/A
- BWMX N/A
- EPS
- RGNX N/A
- BWMX 0.84
- Revenue
- RGNX $155,782,000.00
- BWMX $751,432,052.00
- Revenue This Year
- RGNX $203.27
- BWMX $6.54
- Revenue Next Year
- RGNX $0.58
- BWMX $6.09
- P/E Ratio
- RGNX N/A
- BWMX $16.05
- Revenue Growth
- RGNX 74.95
- BWMX 4.83
- 52 Week Low
- RGNX $5.04
- BWMX $7.00
- 52 Week High
- RGNX $13.48
- BWMX $14.46
- Technical
- Relative Strength Index (RSI)
- RGNX 49.37
- BWMX 59.47
- Support Level
- RGNX $8.82
- BWMX $13.22
- Resistance Level
- RGNX $10.08
- BWMX $13.85
- Average True Range (ATR)
- RGNX 0.54
- BWMX 0.32
- MACD
- RGNX -0.05
- BWMX -0.10
- Stochastic Oscillator
- RGNX 25.27
- BWMX 54.20
About RGNX REGENXBIO Inc.
Regenxbio Inc is a biotechnology company. Its main activity is the development and commercialization of recombinant adeno associated virus gene therapy to correct an underlying genetic defect. The diseases that the Regenxbio platform targets are metabolic (homozygous familial hypercholesterolemia), neurodegenerative conditions (mucopolysaccharidosis), and retinal diseases (wet age-related macular degeneration, X-linked retinitis pigmentosa). The company derives the majority of its revenue from the United States.
About BWMX Betterware de Mexico S.A.P.I. de C.V.
Betterware de Mexico SAPI de CV is a direct-to-consumer selling company. The company operates through two business segments: the home organization products (Betterware segment or BWM segment) and the beauty and personal care products (B and PC) (JAFRA segment). The Betterware's segment is divided in seven categories of the home organization: Kitchen and food preservation, Home solutions, Bedroom, Bathroom, Laundry & Cleaning, Tech & mobility and wellness. The JAFRA's segment is divided into four categories beauty and personal care: fragrance, color (cosmetics), skin care and toiletries. The company generates a majority of its revenue from the Beauty and personal care (B&PC) (JAFRA segment). Geographically, key revenue for the company is derived from Mexico.